Long-Term Study of MP-214 in Patients With Schizophrenia
Clinical trial NCT01626872 · COMPLETED
Trial details
- NCT number
- NCT01626872
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2016-10-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.